These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31637301)
1. Elective Neck Dissection Versus Observation in Early-Stage (cT1/T2N0) Oral Squamous Cell Carcinoma. Liu JY; Chen CF; Bai CH Laryngoscope Investig Otolaryngol; 2019 Oct; 4(5):554-561. PubMed ID: 31637301 [TBL] [Abstract][Full Text] [Related]
2. Elective node dissection versus observation for management of patients with early-stage cT1/T2N0 tongue carcinoma: A systematic review and meta-analysis of prospective studies. Alsini AY; Alsubaie HM; Marzouki HZ; Abu-Zaid A; Al-Qahtani K Clin Otolaryngol; 2021 Jul; 46(4):720-728. PubMed ID: 33840160 [TBL] [Abstract][Full Text] [Related]
3. Elective Neck Dissection vs Observation in Early-Stage Squamous Cell Carcinoma of the Oral Tongue With No Clinically Apparent Lymph Node Metastasis in the Neck: A Systematic Review and Meta-analysis. Abu-Ghanem S; Yehuda M; Carmel NN; Leshno M; Abergel A; Gutfeld O; Fliss DM JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):857-65. PubMed ID: 27442962 [TBL] [Abstract][Full Text] [Related]
4. Neck observation versus elective neck dissection in management of clinical T1/2N0 oral squamous cell carcinoma: a retrospective study of 232 patients. Liu X; Lao X; Liang L; Zhang S; Li K; Liao G; Liang Y Chin J Cancer Res; 2017 Jun; 29(3):179-188. PubMed ID: 28729768 [TBL] [Abstract][Full Text] [Related]
5. Sentinel Lymph Node Biopsy Versus Elective Node Dissection in Stage cT1-2N0 Oral Cavity Cancer. Saleem MI; Peng T; Zhu D; Wong A; Pereira LM; Tham T Laryngoscope; 2022 May; 132(5):989-998. PubMed ID: 34637145 [TBL] [Abstract][Full Text] [Related]
6. Neck nodal recurrence and survival of clinical T1-2 N0 oral squamous cell carcinoma in comparison of elective neck dissection versus observation: A meta-analysis. Cai H; Zhu Y; Wang C; Zhang Y; Hou J Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Apr; 129(4):296-310. PubMed ID: 32107184 [TBL] [Abstract][Full Text] [Related]
7. Elective Neck Dissection Versus Therapeutic Neck Dissection in Clinically Node-Negative Early Stage Oral Cancer: A Meta-analysis of Randomized Controlled Trials. Kumar A; Ghai S; Mhaske S; Singh R J Maxillofac Oral Surg; 2022 Jun; 21(2):340-349. PubMed ID: 35712441 [TBL] [Abstract][Full Text] [Related]
8. Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx. Böscke R; Cakir BD; Hoffmann AS; Wiegand S; Quetz J; Meyer JE Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):567-74. PubMed ID: 23661061 [TBL] [Abstract][Full Text] [Related]
9. Elective Neck Dissection Versus Wait-and-Watch Policy for Oral Cavity Squamous Cell Carcinoma in Early Stage: A Systematic Review and Meta-Analysis Based on Survival Data. Cao Y; Wang T; Yu C; Guo X; Li C; Li L J Oral Maxillofac Surg; 2019 Oct; 77(10):2154-2167. PubMed ID: 31014965 [TBL] [Abstract][Full Text] [Related]
10. Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database. Wushou A; Yibulayin F; Sheng L; Luo Y; Yang ZC BMC Cancer; 2021 Dec; 21(1):1309. PubMed ID: 34876079 [TBL] [Abstract][Full Text] [Related]
11. The role of elective neck dissection in early stage buccal cancer. Huang SF; Chang JT; Liao CT; Kang CJ; Lin CY; Fan KH; Wang HM; Chen IH Laryngoscope; 2015 Jan; 125(1):128-33. PubMed ID: 25043680 [TBL] [Abstract][Full Text] [Related]
12. Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: essential or not? A systematic review and meta-analysis. Ibrahim SA; Ahmed ANA; Elsersy HA; Darahem IMH Eur Arch Otorhinolaryngol; 2020 Jun; 277(6):1741-1752. PubMed ID: 32100133 [TBL] [Abstract][Full Text] [Related]
13. Tumor-stroma ratio is a crucial histological predictor of occult cervical lymph node metastasis and survival in early-stage (cT1/2N0) oral squamous cell carcinoma. Huang S; Cai H; Song F; Zhu Y; Hou C; Hou J Int J Oral Maxillofac Surg; 2022 Apr; 51(4):450-458. PubMed ID: 34412929 [TBL] [Abstract][Full Text] [Related]
14. Elective Neck Dissection Versus Observation in cT1-T2 Oral Tongue Squamous Cell Carcinoma: A Meta-Analysis of 11,973 Patients. Akheel M; George RK; Tiwari S; Jain A; Chahwala Q; Wadhwania A Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2256-2264. PubMed ID: 36452646 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors Associated with Occult Nodal Metastasis and Outcomes for cT1-2N0 Maxillary and Mandibular gingival Carcinoma: A Retrospective Study. Le JM; Sayre KS; Sesanto R; Seri C; Ying YP; Morlandt AB J Maxillofac Oral Surg; 2024 Aug; 23(4):959-965. PubMed ID: 39118910 [TBL] [Abstract][Full Text] [Related]
16. Elective versus therapeutic neck dissection in node-negative oral cancer: Evidence from five randomized controlled trials. Ren ZH; Xu JL; Li B; Fan TF; Ji T; Zhang CP Oral Oncol; 2015 Nov; 51(11):976-981. PubMed ID: 26321080 [TBL] [Abstract][Full Text] [Related]
17. Perineural invasion in T1 oral squamous cell carcinoma indicates the need for aggressive elective neck dissection. Tai SK; Li WY; Yang MH; Chu PY; Wang YF Am J Surg Pathol; 2013 Aug; 37(8):1164-72. PubMed ID: 23681077 [TBL] [Abstract][Full Text] [Related]
18. Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis. Massey C; Dharmarajan A; Bannuru RR; Rebeiz E Laryngoscope; 2019 Aug; 129(8):E284-E298. PubMed ID: 30570760 [TBL] [Abstract][Full Text] [Related]
19. Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer. Wu CN; Chuang HC; Lin YT; Fang FM; Li SH; Chien CY Onco Targets Ther; 2017; 10():3917-3924. PubMed ID: 28831266 [TBL] [Abstract][Full Text] [Related]
20. Contralateral Regional Recurrence in Lateralized or Paramedian Early-Stage Oral Cancer Undergoing Sentinel Lymph Node Biopsy-Comparison to a Historic Elective Neck Dissection Cohort. Mahieu R; den Toom IJ; Boeve K; Lobeek D; Bloemena E; Donswijk ML; de Keizer B; Klop WMC; Leemans CR; Willems SM; Takes RP; Witjes MJH; de Bree R Front Oncol; 2021; 11():644306. PubMed ID: 33968742 [No Abstract] [Full Text] [Related] [Next] [New Search]